Article -> Article Details
| Title | Fetal macrosomia market Analysis, Share, Growth, Trends and Forecast 2023 |
|---|---|
| Category | Fitness Health --> Addictions |
| Meta Keywords | Fetal macrosomia market |
| Owner | vinit |
| Description | |
| Market Highlights The global fetal
macrosomia market has been evaluated as a steady market and it
is expected to continue growing in the near future. Increasing incidence of
fetal macrosomia is the major driver for this market. Introduction and
increasing adoption of advanced diagnostic tools for effective diagnostic and
treatment management is another important factor for the market growth.
Companies are investing in development of new and innovative device development
is also key driver for the market growth. The market for fetal macrosomia was around USD 2290.2
million in 2016 and is expected to reach USD 3034.1 million by 2023 which is a
projected CAGR of 4.1%. Major players in fetal macrosomia market There are plenty of large and small market players which
operate in this market: Carestream Health (US), Esaote SpA (Italy),
Fonar Corporation (US), Fujifilm Holdings Corporation (Japan), GE
Healthcare (UK), Hitachi Medical Corporation (Japan), Hologic, Inc.
(US), Philips Healthcare (Netherlands), Samsung Medison Co. Ltd
(Republic of Korea), Shimadzu Corporation (Japan), Siemens
Healthcare (Germany), Toshiba Corporation (Japan),) and others. Regional Analysis: Considering the global scenario of the fetal macrosomia
market, there are four main regions, America, Europe, Asia Pacific, and Middle
East & Africa. America is the largest market for fetal macrosomia. The
Americas mainly include North America and South America. North America is
holding the largest market share in which US is dominating this market. Some
major factors like advanced diagnostic and treatment facilities, rapid adoption
of healthcare practices, and increasing investment in research are the driving
forces for the growth for North America fetal macrosomia market. European
region is the second important market, especially West European countries are
dominating this region. Eastern European countries are also showing significant
growth in this market. Asia Pacific market is witnessing rapid growth due to
increasing awareness of the diseases, increasing spending and government
initiative to increase awareness as well as to provide affordable healthcare.
Talking about the market scenario of Middle East & Africa, this
region is expected to grow slower than the global average due to various
inhibiting factors such as lack of knowledge, limited access to the required
healthcare facilities, traditional healthcare facilities etc. Segmentation: Global fetal macrosomia market has been segmented on the
basis of diagnosis which comprise of ultrasound, antenatal testing, and others.
Ultrasound is further sub-segmented into standard ultrasound, transvaginal
scan, fetal echocardiography, 3-d ultrasound, dynamic 3-d ultrasound, and
others. Antenatal testing is further sub-segmented into blood and urine tests,
amniocentesis, chorionic villus sampling, and others. On the basis of treatments, the market has been segmented
into medical care, surgical care, and others. Surgical Care is sub-segmented
into cesarean delivery, and others. On the basis of end user, it is segmented into hospital and
clinics, medical research centers, academic institutes, and others. About Market Research Future: MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients. Our market
research studies by products, services, technologies, applications, end users,
and market players for global, regional, and country level market segments, enable
our clients to see more, know more, and do more, which help to answer all their
most important questions. In order to stay updated with technology and work process of
the industry, MRFR often plans & conducts meet with the industry experts
and industrial visits for its research analyst members. | |